MBB Public Markets I LLC Acquires Shares of 8,900 The Clorox Company (NYSE:CLX)

MBB Public Markets I LLC bought a new position in shares of The Clorox Company (NYSE:CLX) in the 2nd quarter, HoldingsChannel reports. The fund bought 8,900 shares of the company’s stock, valued at approximately $1,215,000.

Several other hedge funds and other institutional investors also recently made changes to their positions in the business. Vanguard Group Inc. boosted its stake in Clorox by 0.3% during the 1st quarter. Vanguard Group Inc. now owns 15,277,580 shares of the company’s stock valued at $2,339,150,000 after purchasing an additional 48,632 shares during the last quarter. Nuance Investments LLC boosted its position in shares of Clorox by 150.6% during the second quarter. Nuance Investments LLC now owns 1,597,674 shares of the company’s stock valued at $218,035,000 after buying an additional 960,094 shares during the last quarter. Van ECK Associates Corp grew its holdings in Clorox by 1,715.5% during the second quarter. Van ECK Associates Corp now owns 1,461,207 shares of the company’s stock worth $199,411,000 after buying an additional 1,380,724 shares in the last quarter. Point72 Asset Management L.P. bought a new stake in Clorox during the fourth quarter worth $144,844,000. Finally, Bank of New York Mellon Corp raised its position in Clorox by 14.4% in the 2nd quarter. Bank of New York Mellon Corp now owns 961,387 shares of the company’s stock valued at $131,200,000 after buying an additional 120,716 shares during the last quarter. 78.53% of the stock is owned by institutional investors.

Clorox Trading Down 0.3 %

Shares of Clorox stock opened at $162.90 on Tuesday. The stock has a market capitalization of $20.23 billion, a P/E ratio of 84.40, a P/E/G ratio of 3.31 and a beta of 0.40. The Clorox Company has a 52-week low of $114.68 and a 52-week high of $169.09. The company has a debt-to-equity ratio of 5.04, a quick ratio of 0.63 and a current ratio of 1.03. The stock’s 50-day simple moving average is $152.52 and its 200 day simple moving average is $144.04.

Clorox (NYSE:CLX) last posted its quarterly earnings results on Thursday, August 1st. The company reported $1.82 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.54 by $0.28. The company had revenue of $1.90 billion for the quarter, compared to analyst estimates of $1.97 billion. Clorox had a net margin of 3.95% and a return on equity of 281.12%. As a group, research analysts anticipate that The Clorox Company will post 6.63 EPS for the current year.

Clorox Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, November 7th. Stockholders of record on Wednesday, October 23rd will be given a $1.22 dividend. This represents a $4.88 annualized dividend and a dividend yield of 3.00%. The ex-dividend date of this dividend is Wednesday, October 23rd. Clorox’s dividend payout ratio (DPR) is presently 252.85%.

Insider Activity

In other Clorox news, EVP Angela C. Hilt sold 1,733 shares of the firm’s stock in a transaction dated Friday, September 6th. The stock was sold at an average price of $165.52, for a total value of $286,846.16. Following the completion of the transaction, the executive vice president now owns 13,471 shares in the company, valued at approximately $2,229,719.92. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. 0.51% of the stock is owned by company insiders.

Analyst Ratings Changes

Several analysts have recently issued reports on the stock. Citigroup upped their target price on shares of Clorox from $165.00 to $170.00 and gave the stock a “neutral” rating in a research note on Friday, September 6th. Wells Fargo & Company reduced their price objective on shares of Clorox from $135.00 to $130.00 and set an “underweight” rating for the company in a research report on Wednesday, July 10th. Barclays lifted their target price on shares of Clorox from $122.00 to $130.00 and gave the stock an “underweight” rating in a research report on Monday, August 5th. Deutsche Bank Aktiengesellschaft upped their target price on Clorox from $144.00 to $151.00 and gave the company a “hold” rating in a report on Friday, August 2nd. Finally, DA Davidson reiterated a “neutral” rating and set a $153.00 price target on shares of Clorox in a report on Friday, September 6th. Six equities research analysts have rated the stock with a sell rating and twelve have issued a hold rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $143.33.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.